{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:59:40Z","timestamp":1791341980454,"version":"4.3.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1097\/iae.0000000000004673","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T20:01:00Z","timestamp":1757966460000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Enucleation of an Eye With Potential High-Risk Retinoblastoma Is Currently Important for Patient Survival"],"prefix":"10.1097","volume":"46","author":[{"given":"Carol L.","family":"Shields","sequence":"first","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Lally","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amish C.","family":"Shah","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Service at Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251218","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archopht.120.7.923","article-title":"Postenucleation adjuvant therapy in high-risk retinoblastoma","volume":"120","author":"Honavar","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R2-20251218","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archophthalmol.2011.289","article-title":"Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma","volume":"129","author":"Kaliki","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"R3-20251218","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaophthalmol.2021.4732","article-title":"Defining high-risk retinoblastoma: a multicenter global survey","volume":"140","author":"Kaliki","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"R4-20251218","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1200\/JCO.18.01808","article-title":"Study of unilateral retinoblastoma with and without histopathologic high-risk features and the role of adjuvant chemotherapy: a children's Oncology group study","volume":"37","author":"Ch\u00e9vez-Barrios","year":"2019","journal-title":"J Clin Oncol"},{"key":"R5-20251218","first-page":"1548","article-title":"Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre","volume":"104","author":"Shields","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R6-20251218","doi-asserted-by":"crossref","first-page":"150.e1","DOI":"10.1016\/j.jaapos.2020.12.006","article-title":"Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex","volume":"25","author":"Shields","year":"2021","journal-title":"J AAPOS"},{"key":"R7-20251218","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jamaophthalmol.2015.3108","article-title":"Treatment of retinoblastoma in 2015: agreement and disagreement","volume":"133","author":"Abramson","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R8-20251218","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.oret.2025.02.013","article-title":"Intraarterial chemotherapy for retinoblastoma, outcomes analysis in 357 eyes. Thirteen years of experience in a referral center in Brazil","volume":"9","author":"Teixera","year":"2025","journal-title":"Ophthalmol Ret"},{"key":"R9-20251218","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ophtha.2012.10.044","article-title":"High-risk retinoblastoma based on international classification of retinoblastoma. Analysis of 519 enucleated eyes","volume":"120","author":"Kaliki","year":"2013","journal-title":"Ophthalmology"},{"key":"R10-20251218","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1001\/jama.2024.19981","article-title":"Three vs 6 cycles of chemotherapy for high-risk retinoblastoma: a randomized clinical trial","volume":"332","author":"Ye","year":"2024","journal-title":"JAMA"},{"key":"R11-20251218","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jamaophthalmol.2024.4859","article-title":"Three vs 6 cycles of adjuvant chemotherapy for retinoblastoma","volume":"142","author":"Leahey","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"R12-20251218","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8","article-title":"Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors","volume":"73","author":"Shields","year":"1994","journal-title":"Cancer"},{"key":"R13-20251218","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/bjo.77.9.544","article-title":"Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors","volume":"77","author":"Shields","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"R14-20251218","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bjo.77.9.541","article-title":"Factors influencing metastasis in retinoblastoma","volume":"77","author":"Hungerford","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"R15-20251218","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/IAE.0000000000004250","article-title":"High-risk histopathological features of retinoblastoma following primary enucleation: a global study of 1426 patients from 5 continents","volume":"44","author":"Kaliki","year":"2024","journal-title":"Retina"},{"key":"R16-20251218","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.oret.2025.01.020","article-title":"High-risk retinoblastoma based on international classification systems: analysis of 1362 eyes","volume":"9","author":"Kurian","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"R17-20251218","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/IAE.0000000000004340","article-title":"Neovascular glaucoma as a predictor of retinoblastoma high-risk histopathology in an international multicentre study","volume":"45","author":"Negretti","year":"2025","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:00:18Z","timestamp":1766073618000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004673","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}